Duration: CME/CE Points: Author(s):
-
CME : 0.5
-

Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease is organized by American Academy of Neurology (AAN).

Dates:
Released: 1/17/2020
Expires: 1/17/2023

Accreditation:
The American Academy of Neurology designates that participants earn 0.5 AMA PRA Category 1 CME Credits™ for completion of each multiple-choice podcast exam. Physicians should only claim credit commensurate with the extent of their participation in the activity. CME expires three years after publication date or sooner if podcasts are deemed out of date by reviewers.

Learning Objectives:
Upon completion of this podcast, participants will be able to understand that first ruling out PMP22 duplication/deletion, then considering a targeted genetic testing approach as outlined, in selected patients will increase diagnostic yield in Charcot-Marie-Tooth disease.

Target Audience

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

Fees

Activity Fee : Fee Details will be updated soon
Interested

Specialties

Neurology, Orthopedics, Podiatry, Physical Therapy

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.

Recommended